News tagged with diffuse large b cell lymphoma
Microsoft co-founder Allen treated for lymphoma
Nov 17, 2009 |
not rated yet |
0
(AP) -- Microsoft Corp. co-founder and billionaire investor Paul Allen has been diagnosed with non-Hodgkin's lymphoma and is undergoing chemotherapy.
Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
Jun 24, 2009 |
not rated yet |
0
(PhysOrg.com) -- Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease.
Search results for diffuse large b cell lymphoma
Statins do not interfere with rituximab treatment for lymphomas, study finds
Dec 09, 2008 |
not rated yet |
0
Statins, drugs widely prescribed to lower cholesterol, do not interfere with a commonly used medication to treat lymphomas, according to a Mayo Clinic study presented today at the 50th Annual Meeting of the American Soc ...
Drinking wine may increase survival among non-Hodgkin's lymphoma patients
Apr 21, 2009 |
not rated yet |
0
Pre-diagnostic wine consumption may reduce the risk of death and relapse among non-Hodgkin's lymphoma patients, according to an epidemiology study presented at the American Association for Cancer Research 100th Annual Meeting ...
Novel test identifies leukemia patients likely to respond to new therapy
Feb 20, 2007 |
5 / 5 (2) |
0
Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. ...
The symptoms of T-cell leukemia/lymphoma
Dec 01, 2008 |
2 / 5 (1) |
0
Multiple lymphomatous polyposis (MLP) is an unusual form mantle cell lymphoma characterized by polyps throughout the gastrointestinal tract. Adult T-cell leukemia/lymphoma (ATLL) is a malignancy associated with retrovirus, ...
Two targeted therapies likely better than one in patients with aggressive lymphoma
May 15, 2009 |
not rated yet |
0
When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse large B-cell lymphoma, according to Mayo Clinic researchers working ...
Quantitative PET imaging finds early determination of effectiveness of cancer treatment
Oct 23, 2007 |
4 / 5 (2) |
0
With positron emission tomography (PET) imaging, seeing is believing: Evaluating a patient’s response to chemotherapy for non-Hodgkin lymphoma (NHL) typically involves visual interpretation of scans of cancer tumors. Researchers ...
New cancer target for non-Hodgkin's lymphoma
Nov 22, 2009 |
5 / 5 (1) |
0
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...
Researchers identify novel regulatory mechanism in inflammatory signaling of immune cells
Jan 08, 2009 |
5 / 5 (1) |
1
(PhysOrg.com) -- Using cancer cells that were originally isolated from an anaplastic large cell lymphoma patient, two researchers, including a faculty member of The University of Texas at Austin's College of Pharmacy, have ...
Iron induces death in tumor cells
Mar 11, 2009 |
4 / 5 (1) |
0
Rapid growth of cancer cells and their frequent divisions have their price: Cancer cells need considerably more energy than healthy cells. Their metabolism runs at full speed and requires large amounts of micronutrients, ...
Cancer researchers at the University of Pennsylvania discover what makes lymphomas tick
Aug 29, 2007 |
3.5 / 5 (6) |
0
University of Pennsylvania researchers and their colleagues at the Wistar Institute and University of Oxford have discovered the molecular process by which the PAX5 protein, necessary for lymphocyte development, promotes ...
List of search results for diffuse large b cell lymphoma
